首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A(1c) on the ARCHITECT c8000 chemistry system
【24h】

Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A(1c) on the ARCHITECT c8000 chemistry system

机译:在ARCHITECT c8000化学系统上评估血红蛋白A(1c)的下一代直接全血酶法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: The utility of HbA(1c) for the diagnosis of type 2 diabetes requires an accurate, precise and robust test measurement system. Currently, immunoassay and HPLC are the most popular methods for HbA(1c) quantification, noting however the limitations associated with some platforms, such as imprecision or interference from common hemoglobin variants. Abbott Diagnostics has introduced a fully automated direct enzymatic method for the quantification of HbA(1c) from whole blood on the ARCHITECT chemistry system.
机译:背景:HbA(1c)用于诊断2型糖尿病的实用性需要一个准确,精确和强大的测试测量系统。目前,免疫分析和HPLC是HbA(1c)定量的最流行方法,但是要注意与某些平台相关的局限性,例如不精确或常见血红蛋白变异体的干扰。雅培诊断技术公司推出了一种全自动直接酶法,用于在ARCHITECT化学系统上从全血中定量HbA(1c)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号